Search clinical trials for: DPP-IV Inhibitor
Total 67730 results
-
Kaiser PermanenteActive, not recruitingPreDiabetes | Type 2 DiabetesUnited States
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Mexico, United States, Estonia, Bulgaria, Latvia, Romania, Lithuania, Puerto Rico, Costa Rica
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Australia, Italy, United States, Germany, Canada, Puerto Rico
-
Beni-Suef UniversityFaculty of Medicine, Minia University; Clinical Pharmacy Department, Faculty...Not yet recruiting
-
Mitsui Memorial HospitalMitsukoshi Health and Welfare FoundationCompletedHeart Failure | Diabetes MellitusJapan
-
Northwestern UniversityWashington University School of MedicineRecruiting
-
The Catholic University of KoreaCompletedDiabetes MellitusKorea, Republic of
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesJapan
-
Brigham and Women's HospitalJohns Hopkins University; National Institute on Aging (NIA); Rutgers UniversityActive, not recruiting
-
Umeå UniversityCounty Council of Norrbotten, SwedenCompletedHypertension | Obesity | Type 2 Diabetes | DyslipidemiaSweden
-
Nanjing Medical UniversityUnknown
-
LMC Diabetes & Endocrinology Ltd.Merck Sharp & Dohme LLC; Syreon CorporationWithdrawnType2 Diabetes
-
TakedaCompleted
-
University of British ColumbiaTerminated
-
University of British ColumbiaMerck Sharp & Dohme LLCTerminatedIslet TransplantationCanada
-
Federal University of São PauloNovartisUnknownType 1 Diabetes | Autoimmune Diabetes | Insulin Dependent Diabetes | Juvenile Onset Diabetes MellitusBrazil
-
University of British ColumbiaMerck Frosst Canada Ltd.Completed
-
Brigham and Women's HospitalCompleted
-
University of PadovaCompletedType 2 DiabetesItaly
-
Changhua Christian HospitalCompletedType 2 Diabetes Mellitus | Proteinuria
-
Brigham and Women's HospitalCompleted
-
Brigham and Women's HospitalCompleted
-
Ain Shams UniversityCompletedDiabetes Mellitus, Type 1 | NASHEgypt
-
Royal Devon and Exeter NHS Foundation TrustUniversity of ExeterCompletedType 2 DiabetesUnited Kingdom
-
Weill Medical College of Cornell UniversityPatient-Centered Outcomes Research InstituteCompletedDiabetes Mellitus, Type 2 | Renal Insufficiency, ChronicUnited States
-
University Hospital, Gentofte, CopenhagenUniversity of CopenhagenUnknown
-
Brigham and Women's HospitalCompleted
-
SanofiCompletedDiabetes Mellitus, Type 2Korea, Republic of
-
Woman'sAstraZenecaCompletedPolycystic Ovary Syndrome | Disorder of Glucose RegulationUnited States
-
dr. DJ MulderBoehringer IngelheimCompletedType 2 Diabetes MellitusNetherlands
-
Royal Devon and Exeter NHS Foundation TrustKing's College London; King's College Hospital NHS Trust; Newcastle University; Newcastle-upon-Tyne Hospitals NHS Trust and other collaboratorsCompleted
-
Sadat City UniversityBeni-Suef UniversityCompleted
-
Boehringer IngelheimEli Lilly and CompanyActive, not recruiting
-
AkesoChipscreen Biosciences, Ltd.RecruitingSCLC,Extensive StageAustralia, China
-
Chung-Ang UniversityUnknownDiabetes Mellitus, Type 2 | Acute Coronary SyndromeKorea, Republic of
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Korea, Republic of, Finland, Spain, Denmark, Germany, Israel, Japan, Norway, Sweden, Taiwan, United Kingdom
-
Johns Hopkins Bloomberg School of Public HealthNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedPre-diabetesUnited States
-
Kaiser PermanenteCompleted
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2
-
Proteus Digital Health, Inc.Withdrawn
-
Stanford UniversityPatient-Centered Outcomes Research Institute; San Jose State UniversityCompletedDiabetes Mellitus, Type 2 | Metabolic Syndrome | Insulin ResistanceUnited States
-
Boehringer IngelheimCompleted
-
Rockefeller UniversityCompletedMelanoma | Neoplasm MetastasisUnited States
-
University Hospital, Gentofte, CopenhagenCompletedType2 DiabetesDenmark
-
Brigham and Women's HospitalCompletedDiabetes MellitusUnited States
-
SINA Health Education and Welfare TrustHorizon Pharmaceutical Pvt LtdCompletedGlucose Metabolism Disorders | Diabetes Mellitus, Type 2 | Hypoglycemic Agents | EmpagliflozinPakistan